Get started
Author

Deborah A. Protiva

Observed names: D Protiva, D. A. Protiva, D. Protiva, D.A Protiva, D.A. Protiva, Deborah Protiva
OpenAlex ID: A5088307331
Chronic Viral Hepatitis in Renal Transplant Recipients With Allografts Functioning for More Than 20 Years1,2
1999 · Zobair M. Younossi, William E. Braun, et al. · Transplantation · 72
Coronary arteriography and coronary artery disease in 99 diabetic and nondiabetic patients on chronic hemodialysis or renal transplantation programs.
1981 · W E Braun, D Phillips, et al. · PubMed · 45
The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine
1999 · W.E Braun, B.J Richmond, et al. · Transplantation Proceedings · 28
Ultra‐Late Antibody‐Mediated Rejection 30 Years After a Living‐Related Renal Allograft
2005 · David Weinstein, William E. Braun, et al. · American Journal of Transplantation · 19
PDF
Two Major Serologic Events in a Successful Cardiac Transplant Recipient— Circumvention of Hyperacute Rejection Despite a Positive Donor T Lymphocyte Crossmatch and Late Appearance of Probable Antiidiotypic Antibody
1988 · W. E. Braun, L. Klingman, et al. · Transplantation · 11
Hyperhomocysteinemia and other coronary risk factors in 20-year renal transplant recipients (level 5A) with and without coronary heart disease
1999 · W.E Braun, D.A Protiva, et al. · Transplantation Proceedings · 5
A prospective study of cytomegalovirus infections in 78 renal allograft recipients.
1976 · W E Braun, G Nankervis, et al. · PubMed · 5
Emerging profiles in 105 recipients of renal allografts functioning for 20 to 35 years: the “watershed” effect
2001 · W.E Braun, D.A Protiva · Transplantation Proceedings · 4
Results of transplantation with remote-positive proximate-negative T cell antiglobulin crossmatches.
1987 · E Hodge, A Novick, et al. · PubMed · 4
Decreased Total CD19+ B Lymphocytes and the Occurrence of Monoclonal Proteins Are Frequent in Ultra-Long (30 to 44-Year) Renal Transplant Recipients: Implications for Allograft and Patient Survival
2013 · W.E. Braun, D.A. Protiva, et al. · Transplantation Proceedings · 3
Molecular Quiescence, Despite Minimal Immunosuppressive Therapy, Is the Characteristic Profile of Renal Allograft Recipients With More Than 2-decades of Allograft Function.
2004 · T Muthukumar, D Dadhania, et al. · Transplantation · 3
8.4-01 The impact of recombinant erythropoietin (Epo) on pre-transplant recipient sensitization and transplant outcome
1989 · W.E Braun, E.P Paganini, et al. · Human Immunology · 3
Optimization of living-related renal transplantation success through HLA genotyping, MLC stimulation cutoffs, and donor-specific blood transfusions
1982 · W. E. Braun, A. C. Novick, et al. · Cleveland Clinic Journal of Medicine · 3
World-Wide Long-Term (20–40 Years) Renal Transplant Outcomes and Classification of Long-Term Patient and Allograft Survivals
2010 · William E. Braun, Sankar Navaneethan, et al. · Humana Press eBooks · 1
Decreased Numbers of Total CD19+ B Lymphocytes and the Presence of Monoclonal Proteins Are Frequent in Ultra-Long (30-43 Year) Renal Transplant Recipients: Implications for Allograft and Patient Survival
2012 · W. E. Braun, D. A. Protiva, et al. · Transplantation
Clinical, Biochemical, Immunological, and Prognostic Profiles in 20-35 Year Renal Allograft Recipients; the “watershed” Effect.
2000 · William E. Braun, Deborah A. Protiva · Transplantation
The impact of race and gender on crossmatch outcome
1991 · C. McNamara, N. Thorne, et al. · Human Immunology
HLA-DQ, DRW52/53, and BW4/6 compatibility in human cardiac transplantation: Why “Poorly matched” grafts succeed?
1988 · W.E. Braun, R.W. Stewart, et al. · Human Immunology
Works count: 18
Citation count: 206
H-index: 5
I10-index: 5
Year
Topic
Type